JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Kiniksa (KNSA) PT Raised to $40 at JMP Securities, After Company Announces Phase 2 Clinical Trial Of Vixarelimab (KPL-716) In Prurigo Nodularis Meets Primary Efficacy Endpoint
-
Kiniksa (KNSA) PT Lowered to $35 at JMP Securities
-
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
-
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Prices 2.65 Class A Share Common Offering at $18.26/Sh
-
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Public Offering
-
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Public Offering
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Commences 8M Share Public Offering and 2M Share Concurrent Private Placement
-
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering and Concurrent Private Placement
-
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering and Concurrent Private Placement
-
Kiniksa (KNSA) PT Raised to $44 at JMP Securities
-
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
-
JMP Securities Starts Kiniksa (KNSA) at Market Outperform
-
Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference
-
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
-
Kiniksa Pharmaceuticals (KNSA) IPO Opens 36% Higher
-
Kiniksa Pharmaceuticals, Ltd. (KNSA) Prices 8.48M Share IPO at $18/Sh
-
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering

